|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C12N 15/113 | (2010.01) |
| A61K 31/713 | (2006.01) | ||
| A61P 9/00 | (2006.01) |
| (11) | Number of the document | 3880818 |
| (13) | Kind of document | T |
| (96) | European patent application number | 19801033.2 |
| Date of filing the European patent application | 2019-11-13 | |
| (97) | Date of publication of the European application | 2021-09-22 |
| (45) | Date of publication and mention of the grant of the patent | 2022-09-28 |
| (46) | Date of publication of the claims translation | 2022-12-27 |
| (86) | Number | PCT/EP2019/081158 |
| Date | 2019-11-13 |
| (87) | Number | WO 2020/099476 |
| Date | 2020-05-22 |
| (30) | Number | Date | Country code |
| PCT/EP2018/081106 | 2018-11-13 | WO | |
| 19174466 | 2019-05-14 | EP |
| (72) |
RIDER, David Anthony , DE
BETHGE, Lucas , DE
FRAUENDORF, Christian , DE
WEINGAERTNER, Adrien , DE
HAUPTMANN, Judith , DE
DAMES, Sibylle , DE
SCHUBERT, Steffen , DE
TENBAUM, Stephan , DE
|
| (73) |
Silence Therapeutics GmbH ,
Robert-Rössle-Strasse 10, 13125 Berlin,
DE
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Nukleorūgštis, skirta slopinti LPA raišką ląstelėje |
| NUCLEIC ACIDS FOR INHIBITING EXPRESSION OF LPA IN A CELL |
| Payment date | Validity (years) | Amount | |
| 2025-09-23 | 7 | 162.00 EUR |
| 2026-11-13 |